The therapeutic landscape for immune-mediated disorders has undergone a dramatic transformation through interleukin inhibitors, which have progressed from specialized niche treatments to cornerstone targeted therapies across diverse medical specialties. The Interleukin Inhibitors Market currently demonstrates a well-established foundation of regulatory-approved agents, a comprehensive...

The bullous keratopathy treatment market is projected to experience substantial growth over the coming decade, driven by an aging population, increasing prevalence of cataract surgeries, glaucoma procedures, and novel pharmaceutical interventions from key players such as Aurion Biotechnologies, Emmecell, Trefoil Therapeutics, and Cellusion, among others. Bullous Keratopathy Market Insights,...

The LAG-3 Market has moved from a niche immunology focus to a key area in oncology, immuno-oncology combinations, and autoimmune disease research. Interest beyond PD-1/PD-L1 checkpoints has grown, supported by stronger biological insights, expanding clinical pipelines, and data suggesting better outcomes when LAG-3 modulation is used with other therapies. Scientific and clinical backgroundLAG-3...